A Phase 1, First-in-Human Study of the SMARCA2 Degrader, PLX-61639, in Patients with SMARCA4-Mutated Locally Advanced or Metastatic Solid Tumors
Clinical Trial Grant
Awarded By
Plexium, Inc.
Start Date
February 17, 2026
End Date
February 22, 2031
Awarded By
Plexium, Inc.
Start Date
February 17, 2026
End Date
February 22, 2031